Providence Health & Services
Providence Health & Services
Explore linked clinical trials.35 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAN1012 in Pre-Malignant DCIS and LCIS | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, lobular breast carcinoma in situ, neoplasm, skin disorder | Recruiting | Phase 1 | 2026-09-24 | NCT07408856 | |
| Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response | primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-09-23 | NCT06175000 | |
| GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-09-22 | NCT05913388 | |
| Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-09-16 | NCT06353997 | |
| Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Active, not recruiting | Phase 1 | 2026-09-03 | NCT04470024 | |
| A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-07-23 | NCT06719362 | |
| Neoadjuvant Immunoradiotherapy in Head & Neck Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-23 | NCT03247712 | |
| Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 2 | 2026-07-23 | NCT02306954 | |
| CAN1012 in Pre-malignant Oral Dysplasia | Oral Epithelial Dysplasia (OED) | Not yet recruiting | Phase 1 | 2026-06-02 | NCT07620496 | |
| ALS/MND Natural History Study Data Repository | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kennedy disease, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, X-linked disease, amyotrophic lateral sclerosis, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, progressive bulbar palsy, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy | Recruiting | Not stated | 2026-05-20 | NCT05966038 | |
| Re-Purposing the Ordering of Routine Laboratory Tests in Hospitals in British Columbia | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, iatrogenic disease | Recruiting | Not applicable | 2026-05-07 | NCT06359587 | |
| Enhancing Social Connections Among Rural Community Members With Disordered Eating | Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, psychiatric disorder | Not yet recruiting | Not applicable | 2026-05-01 | NCT06788145 | |
| Clinical Outcomes and Patient Satisfaction With Use of the Amma System | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-04-24 | NCT05508984 | |
| Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-04-24 | NCT05349890 | |
| Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-04-24 | NCT04373031 | |
| Ipilimumab for Head and Neck Cancer Patients | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 1 | 2026-04-24 | NCT02812524 | |
| Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-24 | NCT02734290 | |
| Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2026-04-24 | NCT01416831 | |
| Kidney Precision Medicine Project | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Renal Insufficiency, Acute, Urogenital Diseases, acute kidney injury, autoimmune disease, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, kidney failure, metabolic disease, type 1 diabetes mellitus, urinary system disorder | Recruiting | Not stated | 2026-04-14 | NCT04334707 | |
| Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-04-13 | NCT05249114 | |
| Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 | 2026-04-13 | NCT04895761 | |
| Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-04-13 | NCT04520711 | |
| Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Active, not recruiting | Phase 2 | 2026-04-13 | NCT04061980 | |
| Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast carcinoma, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-04-13 | NCT03650894 | |
| ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Active, not recruiting | Phase 2 | 2026-04-13 | NCT02688712 |